Bain Capital Investors LLC

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Bain Capital Investors LLC reported 4 stock positions worth $4.5 billion. Its top holding was Cerevel Therapeutics (CERE) at 61.9% of the portfolio, followed by Surgery Partners (SGRY, 33.2%) and Aveanna Healthcare (AVAH, 4.5%). Its holdings were unchanged from Q4 2023.

Most Recent 13F
Q2 2026
Location
Boston, MA
CIK
0001040508
Portfolio Value
$4.5B (Q1 2024)
SEC Filing
0000950123-24-005302 ↗ filed May 15, 2024

Holdings Value

0$1.0B$2.0B$3.0B$4.0B$5.0B Q1 2024: $4.5B $4.5B Q1 2024 Q2 2024: $4.7B Q2 2024 Q3 2024: $3.8B Q3 2024 Q4 2024: $3.5B Q4 2024 Q1 2025: $3.9B Q1 2025 Q2 2025: $3.1B Q2 2025 Q3 2025: $3.4B Q3 2025 Q4 2025: $4.6B Q4 2025 Q1 2026: $3.3B Q1 2026 Q2 2026: $4.8B Q2 2026

Holdings 4 stocks · $4.5B
CERE Cerevel Therapeutics Holding 61.94% 65,679,781 $2.8B No change
SGRY Surgery Partners Inc. 33.24% 49,946,972 $1.5B No change
AVAH Aveanna Healthcare Holdings 4.53% 81,600,880 $203.2M No change
ADV Advantage Solutions Inc. 0.28% 2,890,000 $12.5M No change

Portfolio Sells Q4 2023 → Q1 2024
None this quarter.

Portfolio Buys Q4 2023 → Q1 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 8$4.8BBOBS, SGRY, AVAH, KMTS, KLRA
Q1 2026 7$3.3BBOBS, SGRY, AVAH, KMTS, WAY
Q4 2025 7$4.6BCOHR, SGRY, KMTS, AVAH, WAY
Q3 2025 6$3.4BSGRY, AVAH, KMTS, WAY, NTNX
Q2 2025 6$3.1BSGRY, WAY, KMTS, AVAH, NTNX
Q1 2025 6$3.9BSGRY, WAY, NTNX, KMTS, AVAH
Q4 2024 5$3.5BSGRY, NTNX, WAY, AVAH, ADV
Q3 2024 5$3.8BSGRY, NTNX, WAY, AVAH, ADV
Q2 2024 5$4.7BCERE, SGRY, WAY, AVAH, ADV
Q1 2024 4$4.5BCERE, SGRY, AVAH, ADV